TapewireFind a company

person · Reporting owner

Wang Kang-Huai

Disclosed activity across 1 company

Tapewire entity
41861
SEC CIK
0002075513

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
CapsoVision, IncCV · Entity 5974Director · See RemarksJune 01, 2026June 03, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

CapsoVision, Inc

Report date June 01, 2026 · Filed June 03, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.90 · Expires 2036-06-01Direct629,304 Reported balance After 2026-06-01 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2026-06-01 · Grant · Acquired 358,344 · Balance 629,304

F1: The options vest as to 25% of the shares subject to the option on June 1, 2027 and as to the remaining 75% of the shares in 36 equal monthly installments thereafter through June 1, 2030, subject to continued service to the Issuer on each such date.

Filing footnotes · ownership attribution and instrument terms

F1: The options vest as to 25% of the shares subject to the option on June 1, 2027 and as to the remaining 75% of the shares in 36 equal monthly installments thereafter through June 1, 2030, subject to continued service to the Issuer on each such date.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 01, 2026 Filed Jun 3, 2026 14:16 UTC CapsoVision, Inc CV · Entity 5974 GrantStock Option (right to buy) · Derivative 358,344 $0.00 Strike: $6.90 $0.00
Disclosure

SEC source: 0002075513-26-000002 · wk-form4_1780510579.xml · derivative · entry 1

Wang Kang-Huai · CIK 0002075513 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 629,304

Underlying: Common Stock · 358,344 shares

Expires 2036-06-01

F1 · derivative.exercise_date: The options vest as to 25% of the shares subject to the option on June 1, 2027 and as to the remaining 75% of the shares in 36 equal monthly installments thereafter through June 1, 2030, subject to continued service to the Issuer on each such date.

Read SEC document
July 03, 2025 Filed Jul 7, 2025 17:25 UTC CapsoVision, Inc CV · Entity 5974 ConversionSeries H Preferred Stock · Derivative 35,947 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-094308 · ownership.xml · derivative · entry 5

Wang Kang-Huai · CIK 0002075513 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,794 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Series A preferred stock, Series C-1 preferred stock, Series D preferred stock and Series H preferred stock automatically converted into approximately 0.3003 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The number of shares reported herein gives effect to a 1-for-3.33 reverse stock split of the Issuer's common stock effected by the Issuer on July 2, 2025 in connection with its initial public offering.

F1 · derivative.exercise_date: Each share of Series A preferred stock, Series C-1 preferred stock, Series D preferred stock and Series H preferred stock automatically converted into approximately 0.3003 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The number of shares reported herein gives effect to a 1-for-3.33 reverse stock split of the Issuer's common stock effected by the Issuer on July 2, 2025 in connection with its initial public offering.

F1 · derivative.expiration_date: Each share of Series A preferred stock, Series C-1 preferred stock, Series D preferred stock and Series H preferred stock automatically converted into approximately 0.3003 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The number of shares reported herein gives effect to a 1-for-3.33 reverse stock split of the Issuer's common stock effected by the Issuer on July 2, 2025 in connection with its initial public offering.

F1 · derivative.underlying_shares: Each share of Series A preferred stock, Series C-1 preferred stock, Series D preferred stock and Series H preferred stock automatically converted into approximately 0.3003 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The number of shares reported herein gives effect to a 1-for-3.33 reverse stock split of the Issuer's common stock effected by the Issuer on July 2, 2025 in connection with its initial public offering.

Read SEC document
July 03, 2025 Filed Jul 7, 2025 17:25 UTC CapsoVision, Inc CV · Entity 5974 ConversionSeries D Preferred Stock · Derivative 11,111 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-094308 · ownership.xml · derivative · entry 4

Wang Kang-Huai · CIK 0002075513 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,336 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Series A preferred stock, Series C-1 preferred stock, Series D preferred stock and Series H preferred stock automatically converted into approximately 0.3003 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The number of shares reported herein gives effect to a 1-for-3.33 reverse stock split of the Issuer's common stock effected by the Issuer on July 2, 2025 in connection with its initial public offering.

F1 · derivative.exercise_date: Each share of Series A preferred stock, Series C-1 preferred stock, Series D preferred stock and Series H preferred stock automatically converted into approximately 0.3003 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The number of shares reported herein gives effect to a 1-for-3.33 reverse stock split of the Issuer's common stock effected by the Issuer on July 2, 2025 in connection with its initial public offering.

F1 · derivative.expiration_date: Each share of Series A preferred stock, Series C-1 preferred stock, Series D preferred stock and Series H preferred stock automatically converted into approximately 0.3003 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The number of shares reported herein gives effect to a 1-for-3.33 reverse stock split of the Issuer's common stock effected by the Issuer on July 2, 2025 in connection with its initial public offering.

F1 · derivative.underlying_shares: Each share of Series A preferred stock, Series C-1 preferred stock, Series D preferred stock and Series H preferred stock automatically converted into approximately 0.3003 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The number of shares reported herein gives effect to a 1-for-3.33 reverse stock split of the Issuer's common stock effected by the Issuer on July 2, 2025 in connection with its initial public offering.

Read SEC document
July 03, 2025 Filed Jul 7, 2025 17:25 UTC CapsoVision, Inc CV · Entity 5974 ConversionSeries C-1 Preferred Stock · Derivative 33,707 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-094308 · ownership.xml · derivative · entry 3

Wang Kang-Huai · CIK 0002075513 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,122 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Series A preferred stock, Series C-1 preferred stock, Series D preferred stock and Series H preferred stock automatically converted into approximately 0.3003 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The number of shares reported herein gives effect to a 1-for-3.33 reverse stock split of the Issuer's common stock effected by the Issuer on July 2, 2025 in connection with its initial public offering.

F1 · derivative.exercise_date: Each share of Series A preferred stock, Series C-1 preferred stock, Series D preferred stock and Series H preferred stock automatically converted into approximately 0.3003 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The number of shares reported herein gives effect to a 1-for-3.33 reverse stock split of the Issuer's common stock effected by the Issuer on July 2, 2025 in connection with its initial public offering.

F1 · derivative.expiration_date: Each share of Series A preferred stock, Series C-1 preferred stock, Series D preferred stock and Series H preferred stock automatically converted into approximately 0.3003 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The number of shares reported herein gives effect to a 1-for-3.33 reverse stock split of the Issuer's common stock effected by the Issuer on July 2, 2025 in connection with its initial public offering.

F1 · derivative.underlying_shares: Each share of Series A preferred stock, Series C-1 preferred stock, Series D preferred stock and Series H preferred stock automatically converted into approximately 0.3003 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The number of shares reported herein gives effect to a 1-for-3.33 reverse stock split of the Issuer's common stock effected by the Issuer on July 2, 2025 in connection with its initial public offering.

Read SEC document
July 03, 2025 Filed Jul 7, 2025 17:25 UTC CapsoVision, Inc CV · Entity 5974 ConversionSeries A Preferred Stock · Derivative 1,407,407 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-094308 · ownership.xml · derivative · entry 2

Wang Kang-Huai · CIK 0002075513 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 422,644 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Series A preferred stock, Series C-1 preferred stock, Series D preferred stock and Series H preferred stock automatically converted into approximately 0.3003 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The number of shares reported herein gives effect to a 1-for-3.33 reverse stock split of the Issuer's common stock effected by the Issuer on July 2, 2025 in connection with its initial public offering.

F1 · derivative.exercise_date: Each share of Series A preferred stock, Series C-1 preferred stock, Series D preferred stock and Series H preferred stock automatically converted into approximately 0.3003 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The number of shares reported herein gives effect to a 1-for-3.33 reverse stock split of the Issuer's common stock effected by the Issuer on July 2, 2025 in connection with its initial public offering.

F1 · derivative.expiration_date: Each share of Series A preferred stock, Series C-1 preferred stock, Series D preferred stock and Series H preferred stock automatically converted into approximately 0.3003 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The number of shares reported herein gives effect to a 1-for-3.33 reverse stock split of the Issuer's common stock effected by the Issuer on July 2, 2025 in connection with its initial public offering.

F1 · derivative.underlying_shares: Each share of Series A preferred stock, Series C-1 preferred stock, Series D preferred stock and Series H preferred stock automatically converted into approximately 0.3003 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The number of shares reported herein gives effect to a 1-for-3.33 reverse stock split of the Issuer's common stock effected by the Issuer on July 2, 2025 in connection with its initial public offering.

Read SEC document
July 03, 2025 Filed Jul 7, 2025 17:25 UTC CapsoVision, Inc CV · Entity 5974 ConversionCommon Stock 446,896 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-25-094308 · ownership.xml · nonDerivative · entry 1

Wang Kang-Huai · CIK 0002075513 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 721,732

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of Series A preferred stock, Series C-1 preferred stock, Series D preferred stock and Series H preferred stock automatically converted into approximately 0.3003 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The number of shares reported herein gives effect to a 1-for-3.33 reverse stock split of the Issuer's common stock effected by the Issuer on July 2, 2025 in connection with its initial public offering.

F1 · balance_after: Each share of Series A preferred stock, Series C-1 preferred stock, Series D preferred stock and Series H preferred stock automatically converted into approximately 0.3003 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The number of shares reported herein gives effect to a 1-for-3.33 reverse stock split of the Issuer's common stock effected by the Issuer on July 2, 2025 in connection with its initial public offering.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.